Zhejiang Hesenna Medicine Co., Ltd., the main body of the Group (hereinafter referred to as HSN), was established in Lishui City, Zhejiang Province in 2020. Based in China and facing the world, HSN is committed to building a pharmaceutical group that provides integrated services of commercialization, supply chain and brand promotion of foreign high-end patented drugs in China. Hesenna (Guangdong) Healthcare Consulting & Servicing Co., Ltd, a wholly-owned subsidiary of HSN, focuses on building professional, compliant and efficient commercial operation, which has established a professional brand image for many high-quality products.

HSN’s professionalism and integrated services in the pharmaceutical field have been highly recognized and trusted by many leading pharmaceutical companies, such as Pharmanovia (UK), Roche (Switzerland), CHEPLAPHARM (Germany), Patheon (France), Piramal (USA), Dr. Reddy’S (India), etc. HSN has established deep strategic partnerships with several pharmaceutical companies in the early stage of the product life cycle, and obtained authorization during the product development and application stage to become the MAH or its local agent in China, leading its filing in China and the professional layout of product branding. HSN currently focuses on two major areas: bone health and women’s health, covering more than 110,000 medical institutions and about 80,000 pharmacies in China.